Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 189
(20)
◽
pp. E711-E720
◽
2016 ◽
Vol 103
(3)
◽
pp. 818-829
◽
Keyword(s):
2015 ◽
Vol 3
(12)
◽
pp. 958-967
◽
Keyword(s):
2018 ◽
Vol 33
(9)
◽
pp. 811-829
◽
Keyword(s):
2013 ◽
Vol 178
(2)
◽
pp. 159-171
◽
Keyword(s):